Xellsmart

Suzhou, China · Founded 2021 · Privately Held (backing)

Developer of stem cell treatment solutions intended to improve major disease treatment and drug discovery. Xellsmart is based in Suzhou, China and was founded in 2021. Its last reported valuation was $158 million in Mar 2023. It has raised $156 million.

Last reported valuation
$158.0M
Oct 2026
Priced at
—
Total raised
$156.1M
Last round
—

Who backs Xellsmart?

34 investors
InvestorType
Suzhou Oriza Holdings CorporationAsset manager
HSG (Hong Kong)Other
Qiming Venture PartnersVenture capital
YuanBio Venture CapitalVenture capital
Frees FundOther
Leader Venture CapitalOther
Huatai Zijin InvestmentOther
Founder Hesheng InvestmentOther
Tailong VCOther
Teda VCOther
+ 24 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Xellsmart investors

Free account
More of Xellsmart with a free account
  • ·The complete investor list: 34 names
  • ·Watch Xellsmart: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 34 firms already write checks for companies like Xellsmart. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View